U.S. pharma large copyright scrapped two experimental weight loss drugs very last year—a as soon as-daily pill, lotiglipron, due to elevated liver enzymes along with a two times-everyday capsule, danuglipron, because of potent Unwanted side effects—but CEO Albert Bourla has reported the company is decided to “Perform and get” from the obesi